← Evidence map

ArticleFrontiers in endocrinology2025

Teplizumab: a promising intervention for delaying type 1 diabetes progression.

Muhammad Rizwan Saleem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40357199